This inventor holds 7 USPTO granted patents. Top assignees: Ferring Ab, Ferring B.v.. Active years: 1996-1999.
Company Filing History:
Years Active: 1996-1999
Title: Jan-Ake Skoldback: Innovator in Cyclic Peptide Synthesis
Introduction
Jan-Ake Skoldback is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of peptide synthesis, holding a total of 7 patents. His work focuses on improving processes that enhance the quality and efficiency of peptide production.
Latest Patents
One of his latest patents is titled "Synthesis of cyclic peptides." This patent describes a process for preparing and purifying cyclic peptides that contain disulfide moieties. The method involves a two-step processing operation, including reverse phase chromatography, which simplifies synthesis and reduces production costs while ensuring a high-quality yield. This improved process is particularly beneficial for the preparation of vasopressin and oxytocin, along with their respective derivatives and analogs. Another significant patent is for "Desmopressin for nocturia, incontinence and enuresis." This patent outlines a process for manufacturing high-purity desmopressin in single batches of substantial size. It also includes a method for treating nocturia, incontinence, and enuresis using the high-purity desmopressin produced from this process.
Career Highlights
Throughout his career, Jan-Ake has worked with prominent companies such as Ferring AB and Ferring B.V. His experience in these organizations has allowed him to refine his expertise in peptide synthesis and contribute to advancements in the pharmaceutical industry.
Collaborations
Jan-Ake has collaborated with notable colleagues, including Krister Larsson and Thomas Mellbrand. These partnerships have further enriched his work and led to innovative solutions in peptide synthesis.
Conclusion
Jan-Ake Skoldback is a distinguished inventor whose contributions to cyclic peptide synthesis have had a significant impact on the pharmaceutical field. His innovative processes continue to enhance the quality and efficiency of peptide production, benefiting various medical applications.